Related Experiment Video
Updated: Oct 7, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells
Rupesh S Patel1,2,3,4, Rodrigo Romero5,6,7, Emma V Watson1,2,3
1Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Abstract:
The GATA4 transcription factor acts as a master regulator of development of multiple tissues. GATA4 also acts in a distinct capacity to control a stress-inducible pro-inflammatory secretory program that is associated with senescence, a potent tumor suppression mechanism, but also operates in non-senescent contexts such as tumorigenesis. This secretory pathway is composed of chemokines, cytokines, growth factors, and proteases. Since GATA4 is deleted or epigenetically silenced in cancer, here we examine the role of GATA4 in tumorigenesis in mouse models through both loss-of-function and overexpression experiments. We find that GATA4 promotes non-cell autonomous tumor suppression in multiple model systems. Mechanistically, we show that Gata4-dependent tumor suppression requires cytotoxic CD8 T cells and partially requires the secreted chemokine CCL2. Analysis of transcriptome data in human tumors reveals reduced lymphocyte infiltration in GATA4-deficient tumors, consistent with our murine data. Notably, activation of the GATA4-dependent secretory program combined with an anti-PD-1 antibody robustly abrogates tumor growth in vivo.
Insights
The GATA4 transcription factor suppresses tumors by activating a secretory program that recruits immune cells. Activating this pathway with an anti-PD-1 antibody halts tumor growth, offering a potential cancer therapy.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- GATA4 is a key developmental regulator that also controls a pro-inflammatory secretory program.
- This program is linked to senescence and tumorigenesis, and GATA4 is often lost in cancer.
- The role of GATA4 in tumor suppression and its underlying mechanisms remain unclear.
Purpose of the Study:
- To investigate the role of GATA4 in tumorigenesis using mouse models.
- To elucidate the mechanisms by which GATA4 influences tumor suppression.
- To explore therapeutic strategies targeting the GATA4-dependent secretory pathway.
Main Methods:
- Loss-of-function and overexpression experiments in mouse models of tumorigenesis.
- Analysis of Gata4-dependent secretory pathways, including chemokines like CCL2.
- Assessment of immune cell involvement, particularly CD8 T cells.
- Transcriptome analysis of human tumors and in vivo efficacy studies of combined therapy.
Main Results:
- GATA4 was found to promote non-cell autonomous tumor suppression across multiple models.
- Gata4-dependent tumor suppression necessitates cytotoxic CD8 T cells and is partially dependent on CCL2.
- Human tumors lacking GATA4 show reduced lymphocyte infiltration, mirroring murine findings.
- Combining GATA4-secretory program activation with anti-PD-1 therapy effectively inhibited tumor growth.
Conclusions:
- GATA4 functions as a non-cell autonomous tumor suppressor.
- The GATA4-dependent secretory program, involving CD8 T cells and CCL2, is crucial for tumor suppression.
- Targeting the GATA4 pathway in combination with immunotherapy presents a promising strategy for cancer treatment.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...